Author: Vikas Kumar
17 January 2023
Global needle-free injection system market is expected to register a CAGR of approx. 13% over the period of 2022-2028. Needle-free injection technology (NFIT) refers to a wide range of drug delivery systems that propel drugs through the skin using forces such as Lorentz, shock waves, gas pressure, or electrophoresis, effectively eliminating the use of hypodermic needles. The user can administer highly viscous drug products more easily with these techniques than with traditional needle and syringe systems. This technology is beneficial not only to the pharmaceutical industry but also to the development of a better world. The user avoids many other issues by using this technology, such as the possibility of needle stick injuries or complications caused by multiple uses of a single needle. This technique is also very useful in mass immunization programmes. The global needle-free injection system market is growing due to its benefits as it improves immune response to vaccines, eliminates risks of needles, and reduces healthcare costs which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in May 2021, Enesi pharma achieves a key milestone in the development of thermostable solid-dose live vaccines against Measles and Rubella and soon entered into clinical trials. Owing to these glaring statistics the demand for needle-free injection systems is anticipated to grow in the forthcoming years as the increasing volume of patients suffering from chronic disease, diabetes and others boosted the growth of the needle-free injection system industry. Moreover, rising awareness about the benefits of needle-free injections and their application in the treatment of cancer, diabetes, and other infectious diseases is fueling the demand for the needle-free injection system market. Furthermore, technological advancement and awareness about the advantages of needle-free injection systems over other conventional techniques are expected to drive the market for the needle-free injection system in the coming years.
Request for Sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=31406
Based on the product, the needle-free injection system market is segmented into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe owing to its high adoption rates and wide availability throughout the globe. Increasing the application of needle-free injections in vaccination, insulin and other drug delivery is likely to boost the segment of the market.
Based on the technology, the market is fragmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Benefits of this technology include faster drug administration, improved dosage accuracy, better diffusion into the tissue, and a faster response rate.
For a detailed analysis of the Global Needle-Free Injection System Market browse through– https://univdatos.com/report/needle-free-injection-system-market/
For a better understanding of the market adoption of the needle-free injection system, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the needle-free injection system industry owing presence of highly regulated and developed healthcare infrastructure, the availability of advanced products due to the presence of major market players in the U.S. coupled with the increasing prevalence of chronic and lifestyle-associated diseases, and rising healthcare spending in this region.
Some of the major players operating in the market include PharmaJet, Crossject SA, Portal Instruments, NuGen Medical Devices Inc, Inovio Pharmaceuticals Inc, Antares Pharma, Inc, Ferring B.V., Medical International Technology Inc, InsuJet, and Glide Pharmaceutical Technologies Limited.
Global Needle-Free Injection System Market Segmentation
Market Insight, by Product
Market Insight, by Technology
Market Insight, by Usability
Market Insight, by Application
Market Insight, by End-Users
Market Insight, by Region
Top Company Profiles
Get a call back
